Healthcare Industry News: HSMN NewsFeed
News Release - April 13, 2017
Additive Orthopaedics Announces FDA Clearance of their Locking Lattice Plating System for the Global Extremities MarketLITTLE SILVER, N.J., April 13, 2017 -- (Healthcare Sales & Marketing Network) -- Additive Orthopaedics, LLC., an early stage orthopaedic device company, today announced that is has received FDA 510(k) clearance for its 3D printed Locking Lattice Plating System, to address stabilization and fusion of fractures, osteotomies, and arthrodesis of small bones.
According to Greg Kowalczyk, President of Additive Orthopaedics, "We are excited to be one of the first companies to leverage the geometric flexibility, clinical advantages and manufacturing cost benefits of additive manufacturing in the orthopaedic plating market. These plates can be implanted either alone with locking or non-locking screws, or in conjunction with our 3D printed bone segments through the use of a connection screw. This allows the surgeon to mix and match any wedge and plate combination for various deformities, complex revisions, or other limb salvage procedures."
This is the Company's third 510(k) clearance leveraging additive manufacturing and fifth product line, which includes their 3D printed core products, biologics, and customs for limb salvage and complex revision cases. Surgeons have implanted over 300 of their individual devices since the first full commercial product launch at the end of 2016. The Company has recently closed a Series A Round of $1M.
About Additive Orthopaedics, LLC.
Additive Orthopaedics is an early stage orthopaedic company focused on the integration of advanced manufacturing and biologics for the benefit of a better patient outcome.
Source: Additive Orthopaedics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.